PodParley PodParley
PodParley
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more episode artwork

EPISODE · May 9, 2017 · 7 MIN

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

from JAMA Editors' Summary

May 09, 2017 edition of the weekly JAMA Editors' Summary

Episode metadata supplied by the publisher feed · Published May 9, 2017

Embed this episode

NOW PLAYING

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

0:00 7:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 7 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on May 9, 2017.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!